Navigation Links
ViroPharma to Present at the Cowen & Company 29th Annual Healthcare Conference
Date:3/11/2009

EXTON, Pa., March 11 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced that Vincent Milano, president and chief executive officer of ViroPharma, will present at the Cowen & Company 29th Annual Healthcare Conference at 11:00 A.M. ET on Wednesday, March 18, 2009. The conference is being held at the Boston Marriott Copley Place.

ViroPharma's presentations will be webcast live for investors through www.viropharma.com and available for a period of 14 days following the conferences.

About ViroPharma Incorporated

ViroPharma Incorporated is a biopharmaceutical company dedicated to the development and commercialization of products that address serious diseases treated by physician specialists and in hospital settings. ViroPharma commercializes Vancocin(R) (vancomycin hydrochloride capsules, USP), approved for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus, including methicillin-resistant strains, and Cinryze(TM) (C1 inhibitor (human)) for routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema (HAE), also known as C1 inhibitor deficiency (for prescribing information on ViroPharma's commercial products, please download the package inserts at http://www.viropharma.com/Products.aspx). ViroPharma currently focuses its drug development activities in diseases including cytomegalovirus (CMV), HAE and C. difficile.

ViroPharma routinely posts information, including press releases, which may be important to investors in the investor relations and media sections of our company's web site, www.viropharma.com. The company encourages investors to consult these sections for more information on ViroPharma and our business.


'/>"/>
SOURCE ViroPharma Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. ViroPharma to Host Investor Teach-In Educational Symposium on Hereditary Angioedema
2. ViroPharma to Release 2008 Fourth Quarter and Full Year Financial Results on February 24, 2009
3. ViroPharma Reports Results of Phase 3 Clinical Trial for Maribavir in Bone Marrow Transplant Patients
4. ViroPharma to Present at the 27th Annual J.P. Morgan Healthcare Conference
5. ViroPharma Provides Update on Vancocin(R)
6. ViroPharma Submits Supplemental Biologics License Application for Cinryze(TM) to Treat Acute Attacks of Hereditary Angioedema
7. ViroPharma To Present At The 20th Annual Piper Jaffray Healthcare Conference
8. ViroPharma to Discuss Commercialization and Launch of Cinryze(TM) on November 5, 2008
9. ViroPharma Incorporated Reports Third Quarter 2008 Financial Results
10. ViroPharma to Release 2008 Second Quarter Financial Results on July 30, 2008
11. ViroPharma Incorporated Reports First Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... Florida (PRWEB) , ... January 17, 2017 , ... Kevin ... Producers of AsSeenOnTV.pro will be featuring DRTV campaigns regarding the topic of Beauty and ... become a better version of themselves. What better way to commit to these changes ...
(Date:1/17/2017)... ... January 17, 2017 , ... Metro ... approach to infusing high speed technology into the fabric of an entire community. ... advancement of healthcare and wellness in a yet-to-be-named, health focused campus. Leading this ...
(Date:1/17/2017)... ... 17, 2017 , ... Mirror Mirror Beauty Boutique, Houston’s premiere CoolSculpting provider ... in Zeltiq’s Crystal Rewards Program. Practice founder, Paul Vitenas, MD FACS, is delighted that ... , Produced by Zeltiq, CoolSculpting is approved by the Food and Drug Administration ...
(Date:1/17/2017)... Metairie, Louisiana (PRWEB) , ... January 17, 2017 ... ... JenCare Senior Medical Center joined the Peoples Health network on Dec. 1, ... Medicare beneficiaries. , “JenCare Senior Medical Center is an exciting addition to our ...
(Date:1/17/2017)... , ... January 17, 2017 , ... A prescription medication ... of the fourth Cradle to Cradle Product Design Challenge , the Cradle ... a series of six circular design challenges scheduled to run through early 2018. The ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... PARSIPPANY, N.J. , Jan. 17, 2017 Interpace ... that provides clinically useful molecular diagnostic tests and pathology ... it has received a letter dated January 13, 2017 ... it has regained compliance with the requirement of the ... price of $1.00 per share. The letter ...
(Date:1/17/2017)... -- Research and Markets has announced the addition of the ... offering. ... comprehensive report, identifies and profiles the leading 200 manufacturers and distributors of ... the United States and Europe ... . Profile information for each company in The Top ...
(Date:1/17/2017)... 2017 Catherine Amey ... http://www.touchneurology.com/articles/tailored-temperature-management-neurocritical-care ...      (Logo: http://photos.prnewswire.com/prnh/20151014/276718LOGO) ... European Neurological Review , ... reports that despite standard care, temperatures exceeding ...
Breaking Medicine Technology: